Assessing the quality of life in phase I and II anti-cancer drug trials: interviews versus questionnaires

Author： Cox K.  

Publisher： Elsevier

ISSN： 0277-9536

Source： Social Science and Medicine, Vol.58, Iss.3, 2004-02, pp. : 661-661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessing the quality of life of patients in phases I and II anti-cancer drug trials: Interviews versus questionnaires by Cox K

By McKenna S.P.  

Social Science and Medicine, Vol. 58, Iss. 3, 2004-02 ,pp. : 659-660

Elsevier

Access to resources Recommend Favorite

Phase II Study of an ‘All-Oral’ Regimen of Capecitabine, Idarubicin and Cyclophosphamide for Metastatic Breast Cancer – Safety, Efficacy and Quality of Life

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 520-525

Karger

Access to resources Recommend Favorite

Therapeutic Intent in the Conduct of Phase I Antineoplastic Drug Trials

By  

Oncology, Vol. 76, Iss. 3, 2009-01 ,pp. : 149-150

Karger

Access to resources Recommend Favorite

Phase I and Phase II Evaluation of Novel Anticancer Agents: Are Response and Toxicity the Right Endpoints?

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. : 2-6

Karger

Access to resources Recommend Favorite

Quality of Life Measurement in Antidepressant Trials

By  

Psychotherapy and Psychosomatics, Vol. 78, Iss. 4, 2009-04 ,pp. : 212-219

Karger

Access to resources Recommend Favorite